SpaceX is expected to list as SPCX with massive first-day volume; SPXC has a nearly identical ticker, is a real $10B data center cooling play at $230, and trades only ~500k shares daily. Even a tiny fraction of confused retail buyers (1% of 400M shares) would create a multi-million share demand surge, overwhelming normal liquidity and driving price higher. Bet on a short-term name-confusion pump around the SpaceX IPO, with the cushion that SPXC is fundamentally sound (data center infrastructure) so bagholding is not catastrophic. SpaceX IPO may not happen soon or may use a different ticker; confusion effect may be minimal; algos already price in; SPXC could face broader market selloff.
SpaceX is expected to list as SPCX with massive first-day volume; SPXC has a nearly identical ticker, is a real $10B data center cooling play at $230, and trades only ~500k shares daily. Even a tiny fraction of confused retail buyers (1% of 400M shares) would create a multi-million share demand surge, overwhelming normal liquidity and driving price higher. Bet on a short-term name-confusion pump around the SpaceX IPO, with the cushion that SPXC is fundamentally sound (data center infrastructure) so bagholding is not catastrophic. SpaceX IPO may not happen soon or may use a different ticker; confusion effect may be minimal; algos already price in; SPXC could face broader market selloff.
NioCorp has signed a key offtake agreement (Traxys) and its final feasibility study is due imminently (mid-April). These are the last two requirements for a $780M U.S. EXIM loan. Loan approval would de-risk and finance the construction of its Nebraska mine, a critical U.S. rare earth (especially scandium) source, leading to a major re-rating of the stock. The stock is a binary play on the loan approval, with the imminent study release acting as the trigger. Institutional buying (Citadel, BlackRock) suggests smart money agrees. The feasibility study could be negative or show uneconomic metrics. The EXIM loan could still be denied even with a positive study. The company is pre-revenue and burning cash.
NioCorp has signed a key offtake agreement (Traxys) and its final feasibility study is due imminently (mid-April). These are the last two requirements for a $780M U.S. EXIM loan. Loan approval would de-risk and finance the construction of its Nebraska mine, a critical U.S. rare earth (especially scandium) source, leading to a major re-rating of the stock. The stock is a binary play on the loan approval, with the imminent study release acting as the trigger. Institutional buying (Citadel, BlackRock) suggests smart money agrees. The feasibility study could be negative or show uneconomic metrics. The EXIM loan could still be denied even with a positive study. The company is pre-revenue and burning cash.